Evidence map›Paper›PMID 25602870›Full record

ArticleAmerican journal of public health2015

Identifying a sample of HIV-positive beneficiaries from Medicaid claims data and estimating their treatment costs.

Arleen A Leibowitz, Katherine Desmond

Abstract read
In one paragraph

Article in American journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Colorectal Neoplasia among Patients with and without Human Immunodeficiency Virus.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  5. Article
  6. Article
  7. Missed Opportunities for HIV Screening of New Enrollees in California's Low Income Health Program.AIDS education and prevention : official publication of the International Society for AIDS Education · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Transitioning From Medicaid Disability Coverage to Long-Term Medicare Coverage: The Case of People Living With HIV/AIDS in California.AIDS education and prevention : official publication of the International Society for AIDS Education · 2017
    Article
  13. Do Medicare Beneficiaries Living With HIV/AIDS Choose Prescription Drug Plans That Minimize Their Total Spending?Inquiry : a journal of medical care organization, provision and financing · 2017
    Article
  14. Antiretroviral Therapy: Racial Disparities among Publicly Insured Californians with HIV.Journal of health care for the poor and underserved · 2017
    Article
  15. Article
  16. Article
  17. Expenditures for Persons Living With HIV Enrolled in Medicaid, 2006-2010.Journal of acquired immune deficiency syndromes (1999) · 2016
    Article
  18. Observational
  19. The Effect of Hospice on End-of-Life Costs for Terminal Medicare Patients With HIV.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arleen A LeibowitzBoth authors are with the Department of Public Policy, Luskin School of Public Affairs, University of California Los Angeles.
Katherine Desmond

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
HSRD VA CDA 10-016NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NIAID NIH HHS 5P30AI028697NIAID NIH HHS P30 AI028697NIMH NIH HHS MH58107NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

objectivesWe sought to identify people living with HIV/AIDS from Medicare and Medicaid claims data to estimate Medicaid costs for treating HIV/AIDS in California. We also examined how alternate methods of identifying the relevant sample affect estimates of per capita costs.

methodsWe analyzed data on Californians enrolled in Medicaid with an HIV/AIDS diagnosis reported in 2007 Medicare or Medicaid claims data. We compared alternative selection criteria by examining use of antiretroviral drugs, HIV-specific monitoring tests, and medical costs. We compared the final sample and average costs with other estimates of the size of California's HIV/AIDS population covered by Medicaid in 2007 and their average treatment costs.

resultsEighty-seven percent (18,290) of potentially identifiable HIV-positive individuals satisfied at least 1 confirmation criterion. Nearly 80% of confirmed observations had claims for HIV-specific tests, compared with only 3% of excluded cases. Female Medicaid recipients were particularly likely to be miscoded as having HIV. Medicaid treatment spending for Californians with HIV averaged $33,720 in 2007.

conclusionsThe proposed algorithm displays good internal and external validity. Accurately identifying HIV cases in claims data is important to avoid drawing biased conclusions and is necessary in setting appropriate HIV managed-care capitation rates.

Indexed as

Health Care CostsPatient Protection and Affordable Care ActCaliforniaData Interpretation, StatisticalFemaleHIV SeropositivityHumansInsurance Claim ReviewInsurance CoverageMaleMedicaidMedicareUnited States

Identifiers

PMID25602870
PMCPMC4324128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.